Nanox to Participate in the Oppenheimer’s Virtual Fall Healthcare Life Sciences & MedTech Summit
NANO-X IMAGING LTD (NASDAQ: NNOX) announced that its CEO, Ran Poliakine, will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit from September 21-23, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
NANO-X IMAGING LTD (NASDAQ: NNOX) announced that its CEO, Ran Poliakine, will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit from September 21-23, 2020. The presentation is scheduled for September 22, 2020, at 9:10 am ET. The event will be webcast live, with access available through both a dedicated link and the company's website. Nanox focuses on developing a cost-effective digital X-ray source for real-world medical applications aimed at improving early detection services.
Details
News Market Reaction – NNOX
The recorded move for NNOX in the trading session of this news was +24.13%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEVE ILAN, Israel and TAIPEI, Taiwan, Sept. 18, 2020 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that Ran Poliakine, Chairman and Chief Executive Officer, will be participating in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, which is being held virtually from September 21-23, 2020.
Presentation details:
Date: Tuesday, September 22, 2020
Time: 9:10am ET
Audio from the event will be webcast live and may be accessed at the following link: https://wsw.com/webcast/oppenheimer5/nax/2497527 or on the Investors section of the company’s website, www.nanox.vision. The webcasts will be archived and available for replay for a period of 90 days.
About Nanox:
Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.
Investor Contacts:
Itzhak Maayan
Nanox Imaging
IR@nanox.vision
Bob Yedid
LifeSci Advisors
646-597-6989
bob@lifesciadvisors.com
Media Contact:
Alona Stein
ReBlonde for Nanox
alona@reblonde.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.